FDA says hospitals may still have recalled heparin

Despite widespread publicity about heparin problems, several California hospitals were found to still have recalled heparin products in their supply chains, suggesting that the problem could still be an issue nationally, according to the FDA. The agency now has issued a request for hospitals and healthcare workers across the U.S. to search storage areas for possibly overlooked supplies of the drug, tainted versions of which have been blamed for 81 deaths. The recalled products were found last week during visits to California hospitals by the FDA and Baxter International, which made the batches that have since been recalled.

To learn more about the FDA's request:
- read this Modern Healthcare piece (reg. req.)

Related Articles:
Number of heparin-related deaths reported triples
Post-heparin, no oversight excuses

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.